# Dentin Hypersensitivity Reduction Efficacy Clinical

> **NCT07738198** · PHASE3 · COMPLETED · sponsor: **Colgate Palmolive** · enrollment: 116 (actual)

## Conditions studied

- Dental Hypersensitivity

## Interventions

- **DRUG:** 0.454% stannous fluoride toothpaste
- **DRUG:** 5% potassium nitrate
- **DRUG:** 0.76% sodium monofluorophosphate

## Key facts

- **NCT ID:** NCT07738198
- **Lead sponsor:** Colgate Palmolive
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-26
- **Primary completion:** 2018-12-08
- **Final completion:** 2018-12-08
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07738198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07738198, "Dentin Hypersensitivity Reduction Efficacy Clinical". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07738198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*